Provided by Tiger Trade Technology Pte. Ltd.

Beta Bionics, Inc.

22.18
+2.9515.34%
Post-market: 22.15-0.0300-0.14%19:56 EDT
Volume:7.19M
Turnover:151.40M
Market Cap:988.38M
PE:-13.45
High:22.22
Open:18.61
Low:18.40
Close:19.23
52wk High:32.71
52wk Low:8.80
Shares:44.56M
Float Shares:26.52M
Volume Ratio:5.95
T/O Rate:27.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6486
EPS(LYR):-1.8100
ROE:-26.16%
ROA:-16.67%
PB:3.86
PE(LYR):-12.25

Loading ...

Beta Bionics Q2 FY26 Net Loss Widens 39% to $23.4 Million; Net Sales Climb 38% to $32 Million

Reuters
·
Jul 30

Beta Bionics reports Q2 EPS (53c), consensus (56c)

TIPRANKS
·
Jul 30

Beta Bionics backs FY26 revenue view $131M-$136M, consensus $133.48M

TIPRANKS
·
Jul 30

Beta Bionics Q2 Sales Beat Estimates on Pharmacy Channel Growth

Reuters
·
Jul 30

Beta Bionics Q2 EPS $(0.53) Beats $(0.56) Estimate, Sales $32.013M Beat $31.443M Estimate

Benzinga Earnings
·
Jul 30

Beta Bionics Inc Outlook FY Revenue USD 131-136 Million

THOMSON REUTERS
·
Jul 30

Beta Bionics Inc Q2 EPS USD -0.53

THOMSON REUTERS
·
Jul 30

Press Release: Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance

Dow Jones
·
Jul 30

Beta Bionics Coverage Assumed by UBS at Buy

Dow Jones
·
Jul 29

UBS Adjusts Price Target on Beta Bionics to $22 From $24, Maintains Buy Rating

MT Newswires Live
·
Jul 28

Beta Bionics resumed with a Buy at UBS

TIPRANKS
·
Jul 28

Here's Why We're Not Too Worried About Beta Bionics' (NASDAQ:BBNX) Cash Burn Situation

Simply Wall St.
·
Jul 28

Beta Bionics is Maintained at Buy by Goldman Sachs

Dow Jones
·
Jul 16

Beta Bionics is Maintained at Buy by Truist Securities

Dow Jones
·
Jul 14

Beta Bionics price target raised to $22 from $18 at Truist

TIPRANKS
·
Jul 13

Truist Raises Price Target on Beta Bionics to $22 From $18, Keeps Buy Rating

MT Newswires Live
·
Jul 13

Beta Bionics Schedules Q2 2026 Results Webcast and Conference Call

Reuters
·
Jul 01

Beta Bionics CFO Stephen Feider Disposes of USD 173,083.32 in Common Shares

Reuters
·
Jul 01

Beta Bionics Director Christy Jones Sells 1,406 Shares for $21,090

Reuters
·
Jun 26

Beta Bionics Chief Commercial Officer Mark Hopman disposes of 275 common shares for $3,385.25

Reuters
·
Jun 06